Publications by the researcher in collaboration with Amaya García Fernández (18)

2022

  1. Antithrombotic therapy and clinical outcomes at 1 year in the Spanish cohort of the EORP-AF Long-term General Registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 4

  2. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry

    European Journal of Internal Medicine, Vol. 99, pp. 45-56

  3. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

    BMC Medicine, Vol. 20, Núm. 1

  4. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry

    Europace, Vol. 24, Núm. 5, pp. 721-728

  5. Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 7

  6. Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 6

2021

  1. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

    BMC Medicine, Vol. 19, Núm. 1

2020

  1. Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry

    Annals of Medicine, Vol. 52, Núm. 6, pp. 300-309

2018

  1. Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA 2 DS 2 -VASc and HAS-BLED scores using multiple biomarkers

    Annals of Medicine, Vol. 50, Núm. 1, pp. 26-34

2017

  1. Applicability of the modified CHA2DS2-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients

    European Journal of Internal Medicine

  2. Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

    Scientific Reports, Vol. 7

  3. Evaluación de los esquemas de riesgo hemorrágico HAS-BLED y ORBIT en pacientes con fibrilación auricular no valvular tratados con anticoagulación oral

    Revista Espanola de Cardiologia

  4. Strategies for prediction and early detection of atrial fibrillation: Present and future

    Europace

2016

  1. Is the ORBIT bleeding risk score superior to the HAS-BLED score in anticoagulated atrial fibrillation patients?

    Circulation Journal, Vol. 80, Núm. 10, pp. 2102-2108

  2. Long-term predictors of thromboembolic events in nonvalvular atrial fibrillation patients undergoing electrical cardioversion

    Circulation Journal, Vol. 80, Núm. 3, pp. 605-612

  3. The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion

    International Journal of Cardiology, Vol. 217, pp. 42-48

2006

  1. Effect of Statins on Preventing Recurrence of Atrial Fibrillation After Electrical Cardioversion

    American Journal of Cardiology

2002

  1. ¿Debemos pensar en una etiología específica en pacientes con taponamiento cardíaco?

    Revista Espanola de Cardiologia, Vol. 55, Núm. 5, pp. 493-498